Low Intensity Training Combined With KAATSU on Muscle Vasodilatation and Arterial Stiffness in th… (NCT03272737) | Clinical Trial Compass
CompletedNot Applicable
Low Intensity Training Combined With KAATSU on Muscle Vasodilatation and Arterial Stiffness in the Elderly Population
Brazil26 participantsStarted 2018-02-04
Plain-language summary
The purpose of the present study is to evaluate the acute and chronic effect of low intensity strength training with or without moderate blood flow restriction on muscle vasodilation and arterial stiffness in elders with low gait speed. In addition, the responses of prothrombotic factors in blood coagulation, the impact on heart rate and arterial pressure will be assessed.
Who can participate
Age range
60 Years – 85 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Elderly people aged 60 to 85 years, with walking speed \<0.8m / s (Guralnik, 1994).
Exclusion Criteria:
* Elderly patients with uncontrolled diabetes mellitus or peripheral neuropathy;
* Symptomatic peripheral obstructive arterial disease or brachial ankle index \<0.9;
* Uncontrolled arterial hypertension (BP\> 160 / 100mmHg);
* Uncontrolled dyslipidemia (total colostrum\> 220mg / dL);
* Infectious with less than 1 month;
* Osteoarticular or neurological problems that prevent training;
* History of anemia, cerebrovascular disease, myocardial infarction in the last 6 months;
* Pior deep venous thrombosis;
* Use of oral anticoagulant;
* Smoking \<6 months;
* Use of antiplatelet agents and anticoagulants;
* Cognitive dysfunctions: Mini-mental \<24. (Brucki, 2003).
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.